In a sweeping recall that touches the shelves of 40 states, Ventura Foods has pulled more than 20,000 units of peanut butter from the market due to possible plastic contamination, according to reports by the U.S. Food and Drug Administration. Wisconsin residents are among those advised to be vigilant, the FDA having pinpointed the presence of blue plastic discovered during the manufacturing process in a production filter as the reason for the recall, as per the Journal Sentinel.
The implicated brands, produced by Ventura Foods, appear to span various packaging sizes and flavor combinations, including creamy peanut butter packets and twin packs of peanut butter with either strawberry jam or grape jelly; this recall notably follows an initial Class II classification on February 12 by the FDA, which confirms that exposure could cause temporary or medically reversible adverse health effects, as USA Today reports, though the risk of significant harm is considered low.
The details of the specific items pulled from the shelves were disclosed by the FDA, encompassing sizes ranging from 0.5-ounce to 1.12-ounce packets, with these products distributed by multiple brands across the United States, among them US Foods and DYMA Brands, Inc., as detailed by KTVU. The list also features twin packs combining creamy peanut butter with either grape jelly or strawberry jam, with the potential impact of the recall translating into a significant number of units and packages.
For consumers in affected states, including but not limited to California, Texas, New York, Florida, and Ohio, the recommendation stands to check pantries and shelves, with a full list of the states impacted available courtesy of information released by the FDA, confirming the recall’s breadth; which extends from the Atlantic to Pacific coasts, indicating a geographical dispersion of the issue that spans most of the nation. Meanwhile, those seeking to identify if their purchases are subject to recall can find specific product details, lot numbers, and distributor information on the FDA’s website, as advised by sources covering the recall.
